• Biologics, Anti-Inflammatory Drugs Current Focus Of Alzheimer’s Disease Trials

    Clinical Research News | The latest report on clinical trials in the Alzheimer’s drug development pipeline points to the growing potential of anti-amyloid monoclonal antibodies for treating the brain-robbing condition. Anti-inflammatory agents comprise the single largest therapeutic category with 25 drugs, but astoundingly no two are aimed at the same target.

    Jun 21, 2023

  • Rescuing a Study in Jeopardy with Comprehensive Clinical Adjudication

    Clinical Research News | Global clinical trial programs are complex, often encompassing dozens of studies for increasingly uncommon indications. Sponsors of these programs are wisely seeking out independent adjudication of clinical events, or endpoints, that occur over the course of the trial to ensure patient safety and the efficacy of drugs and devices. While endpoint adjudication is not required by regulatory bodies, it can deliver valuable insights during a trial and lend strong, unbiased support for approvals down the road.

    Jun 16, 2023

  • N-Lorem Foundation Bringing Real Hope To ‘N-Of-1’ Patients

    Clinical Research News | Stanley T. Crooke, M.D., Ph.D., founder and longtime leader of the company that pioneered RNA-targeted therapeutics, is now chairman and CEO of the n-Lorem Foundation descaling the technology to treat patients helpless before a healthcare system that wasn’t built for “n-of-1” problems. He will be addressing a room of physicians and scientists tomorrow on the campus of Vanderbilt University.

    Jun 14, 2023